Author:
Williams Bethany Jill,Bottoms David,Treanor Darren
Abstract
This document clarifies the strategic context of digital pathology adoption, defines the different use cases a healthcare provider may wish to consider as part of a digital adoption and summarises existing reasons for digital adoption and its potential benefits. The reader is provided with references to the relevant literature, and illustrative case studies. The authors hope this report will be of interest to healthcare providers, pathology managers, departmental heads, pathologists and biomedical scientists that are considering digital pathology, deployments or preparing business cases for digital pathology adoption in clinical settings. The information contained in this document can be shared and used in any documentation the reader wishes to present for their own institutional case for adoption report or business case.
Subject
General Medicine,Pathology and Forensic Medicine
Reference28 articles.
1. Food and Drug Administration. FDA allows marketing of first whole slide imaging system for digital pathology. 2017. https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm552742.htm (accessed 8 Apr 2017).
2. Cancer Research UK. Testing times to come?An evaluation of pathology capacity across the UK. 2016. http://www.cancerresearchuk.org/sites/default/files/testing_times_to_come_nov_16_cruk.pdf (accessed 10 Feb 2017).
3. Report of the Independent Cancer Taskforce, UK, (July 2015) Achieving World Class Cancer Outcomes. A Strategy for England 2015-2020. http://www.cancerresearchuk.org/sites/default/files/achieving_worldclass_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf (accessed 10 Feb 2017).
4. Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply
5. Pathologist Workforce in the United States: I. Development of a Predictive Model to Examine Factors Influencing Supply
Cited by
93 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献